Your browser doesn't support javascript.
loading
Recurrent Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1 Syndrome.
Libánský, P; Carková, J; Kushnir, I; Matejková Behanová, M; Procyklová, K; Sedý, J; Vaculová, M; Vcelák, J; Zikán, V; Adámek, S.
Afiliação
  • Libánský P; 3rd Department of Surgery, 1st Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. petr.libansky@lf1.cuni.cz.
Physiol Res ; 72(S4): S423-S427, 2023 12 17.
Article em En | MEDLINE | ID: mdl-38116778
ABSTRACT
Primary hyperparathyroidism is a common endocrinopathy. Multiple Endocrine Neoplasia Type 1 (MEN1) is a rare autosomal dominantly inherited endocrine tumor predisposition syndrome, with one of main manifestations being primary hyperparathyroidism. We retrospectively evaluated a set of 1011 patients who underwent surgery for primary hyperparathyroidism between the years 2018-2022, and found 78 (8 %) patients who underwent reoperations and 27 patients with MEN1 syndrome. In the group of patients with MEN1 syndrome, 7 (35 %) needed reoperations. Patients with multiple endocrine neoplasia syndrome have a higher risk of needing reoperation. Genetic testing can help identify MEN1 syndrome preoperatively and to better evaluate the approach to surgery.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasia Endócrina Múltipla Tipo 1 / Hiperparatireoidismo Primário Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasia Endócrina Múltipla Tipo 1 / Hiperparatireoidismo Primário Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article